← Back to headlines
Mirum and Incyte Announce Positive Phase 2 Data for FOP Treatment
Mirum and Incyte have reported positive results from their Phase 2 clinical trial for zilurgisertib, a drug being developed for the treatment of Fibrodysplasia Ossificans Progressiva (FOP).
15 Jun, 06:38 — 15 Jun, 06:38
Sources
Showing 1 of 1 sources
Related Stories
Irish Health Agency Fined €645,000 for Storing Records in Derelict Sites
2h ago
New Urine Test Detects Over 90 Percent of Bladder Cancer Cases
2h ago
Swimmer Hospitalized Following Suspected Shark Attack in Massachusetts
6h ago
Wellington Clinics Suspends Kidney Transplants Amid Organ Harvesting Probe
12h ago